Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,611 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00413283 | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 63 | AmgenINDUSTRY | 8 | Oct 24, 2013 | clinicaltrials |
| NCT00052949 | Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 91 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01086254 |
| SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer |
| completed |
| Phase 2 |
| 119 |
| SanofiINDUSTRY |
| 5 |
| Sep 24, 2013 |
| clinicaltrials |
| NCT01075399 | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors(HX4-200) | completed | Phase 2 | 50 | Siemens Molecular ImagingINDUSTRY | 0 | Aug 30, 2013 | clinicaltrials |
| NCT01368848 | Combination of Cisplatin, Docetaxel and Bevacizumab in Patients With Non-small Cell Lung Carcinoma (NSCLC) | completed | Phase 2 | 7 | Arbeitsgemeinschaft medikamentoese TumortherapieOTHER | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00922584 | Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor | completed | Phase 2 | 65 | Chinese Society of Lung CancerOTHER | 1 | Aug 21, 2013 | clinicaltrials |
| NCT00006470 | Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Aug 13, 2013 | clinicaltrials |
| NCT00583830 | A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer(NSCLC) | completed | Phase 2 | 111 | Human Genome Sciences Inc.INDUSTRY | 4 | Aug 8, 2013 | clinicaltrials |
| NCT00092924 | Study of TRM-1(TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | Human Genome Sciences Inc.INDUSTRY | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00585533 | A Phase 2 Study of Tarceva for Untreated, Good Prognosis Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 40 | University of UtahOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00003111 | Combination Chemotherapy Followed by Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 2 | 10 | Yale UniversityOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00072059 | Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00079235 | CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00702975 | Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic Therapy | completed | Phase 2 | 35 | Radboud University Medical CenterOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT00463515 | Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC(CHER@NOS) | completed | Phase 2 | 77 | University Hospital, AntwerpOTHER | 1 | Jul 12, 2013 | clinicaltrials |
| NCT00022711 | Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer | completed | Phase 2 | 7 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00002475 | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | 40 | St. Vincent Medical Center - Los AngelesOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00003089 | Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 2 | — | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00005091 | DX-8951f in Treating Previously Untreated Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | — | Daiichi PharmaceuticalsINDUSTRY | 5 | Jul 10, 2013 | clinicaltrials |
| NCT00529100 | Concurrent Pemetrexed, Cisplatin and Radiation Therapy in Patients With Stage IIIA/B Non Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 49 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00003037 | Combination Chemotherapy as Induction Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00008255 | INS316 in Diagnosing Lung Cancer in Patients With Untreated Lung Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00036920 | TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00062283 | Alanosine in Treating Patients With Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00600587 | Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 24 | Guangdong Provincial People's HospitalOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00006019 | Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00068289 | Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00003881 | Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 3 | Jun 21, 2013 | clinicaltrials |
| NCT00019084 | Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019331 | Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019929 | Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00871403 | Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 2 | Jun 20, 2013 | clinicaltrials |
| NCT00004238 | 10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00004249 | Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00452634 | Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) | completed | Phase 2 | 62 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00620347 | Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer | completed | Phase 2 | 25 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00027638 | Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00536640 | Inoperable Non-Squamous NSCLC Stage III/IV: A Randomised Phase II Study With Bevacizumab Plus Erlotinib Or Gemcitabine/Cisplatin Plus Bevacizumab(INNOVATIONS) | completed | Phase 2 | 224 | Aktion Bronchialkarzinom e.V.OTHER | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00062101 | Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer | completed | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 6, 2013 | clinicaltrials |
| NCT00040794 | Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer | completed | Phase 2 | 144 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00081107 | Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00006929 | Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer | completed | Phase 2 | 82 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00055757 | Tipifarnib, Gemcitabine, and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00118183 | Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | completed | Phase 2 | 62 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00104793 | Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer | completed | Phase 2 | 55 | Japan Multinational Trial OrganizationOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT01130753 | Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer | completed | Phase 2 | 43 | Samsung Medical CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00601796 | Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer | completed | Phase 2 | 24 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 24, 2013 | clinicaltrials |
| NCT00855894 | A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer(PENGUIN) | completed | Phase 2 | 41 | Genentech, Inc.INDUSTRY | 2 | May 21, 2013 | clinicaltrials |
| NCT00004176 | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer | completed | Phase 2 | 34 | Washington University School of MedicineOTHER | 1 | May 16, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Oct 24, 2013source: clinicaltrials